Group 1 - The company held its fifth board meeting on November 10, 2025, where all five directors attended, meeting the legal quorum requirements [2][3] - The board unanimously approved the proposal to change the purpose of repurchased shares from employee stock ownership plans to cancellation and reduction of registered capital [3][4] - The company plans to cancel 44,916,376 shares, which represents approximately 3.899% of the current total share capital, reducing the total share capital from 1,152,000,200 shares to 1,107,083,824 shares [7][13] Group 2 - The company will convene the 2025 third extraordinary general meeting of shareholders on November 27, 2025, to discuss the approved proposals [5][18] - The meeting will be conducted through a combination of on-site voting and online voting, with specific time slots for each [19][33] - Shareholders must register for the meeting by providing necessary documentation, and the registration period is set for November 26, 2025 [25][26]

Summary of Key Points Core Viewpoint The company held its first extraordinary general meeting of shareholders in 2025, where several important resolutions were passed, including changes to share repurchase purposes and organizational structure adjustments. Group 1: Meeting Details - The extraordinary general meeting was held on September 15, 2025, combining on-site voting and online voting [2][4]. - A total of 45 shareholders and their proxies attended the meeting, representing 72,222,000 shares, which is 72.0479% of the total voting rights [5][6]. - The meeting was legally compliant with relevant laws and regulations [5][6]. Group 2: Resolutions Passed - The resolution regarding the change of share repurchase purpose and capital reduction was approved with 72,179,000 votes in favor, accounting for 99.9405% of the votes [6][8]. - The resolution to adjust the organizational structure and board seats received 72,202,000 votes in favor, representing 99.9723% [9][11]. - The amendment to the company’s articles of association was approved with 72,205,000 votes in favor, which is 99.9765% [12][14]. Group 3: Shareholder Voting Breakdown - Among minority shareholders, 66.1417% voted in favor of the share repurchase resolution [7]. - For the organizational structure adjustment, 84.2520% of minority shareholders supported the resolution [10]. - The amendment to the articles of association saw 86.6142% of minority shareholders voting in favor [13]. Group 4: Legal Opinions and Documentation - The meeting was witnessed by lawyers from Shanghai Haoxin Law Firm, who confirmed the legality and validity of the meeting and its resolutions [67]. - Relevant documents, including the resolutions and legal opinions, are available for review [68].

Group 1 - The company held its first extraordinary general meeting of shareholders on September 10, 2025, in Changchun, with no resolutions being rejected [2] - The meeting was convened by the board of directors and was presided over by the general manager, as the chairman was unable to attend due to official duties [2][3] - All resolutions passed during the meeting were deemed legal and valid according to relevant laws and regulations [6] Group 2 - The meeting approved several key resolutions, including the termination of the 2023 restricted stock incentive plan and the repurchase and cancellation of 6,112,500 unvested restricted stocks [4][10] - The company will reduce its total share capital from 462,995,380 shares to 456,882,880 shares as a result of the stock repurchase [10] - The company also approved the cancellation of the supervisory board and amendments to its articles of association [4][10] Group 3 - The company notified creditors about the reduction in registered capital due to the stock repurchase, allowing them to claim debts within specified timeframes [9][10] - Creditors have 30 days from receiving the notice or 45 days from the announcement date to assert their claims [10][11] - The announcement included details on how creditors can submit their claims, including required documentation and contact information [11][12]

Group 1 - The board of directors of Shenzhen Xinlong Health Industry Development Co., Ltd. held its 14th meeting of the 7th session on August 21, 2025, with 8 out of 11 directors present [1] - The board unanimously approved the 2025 semi-annual report and its summary, confirming compliance with legal and regulatory requirements [1][2] - The semi-annual report will be published on August 23, 2025, on the designated information disclosure media [2] Group 2 - The board approved a proposal to repurchase and cancel 75,000 unvested restricted stocks at an adjusted price of 3.49 yuan per share, which will be submitted for review at the first extraordinary general meeting of 2025 [2][3] - The decision to cancel the restricted stocks was made due to unmet performance targets for the first vesting period of the 2023 restricted stock incentive plan [3] Group 3 - The board unanimously passed a resolution to reduce the registered capital from 368,060,000 yuan to 366,241,950 yuan, and to cancel the supervisory board [4][5] - The company will amend its articles of association accordingly, transferring the supervisory responsibilities to the audit committee of the board [4] Group 4 - The board proposed several amendments to internal governance documents, including the rules for shareholder meetings, board meetings, independent director systems, and audit committee rules, all of which require shareholder approval [5][6][7][8] - The board also nominated candidates for the 8th board of directors, including 6 non-independent directors and 4 independent directors, to be elected at the upcoming shareholder meeting [9][10]